CLDX
Celldex Therapeutics, Inc#79 · 2021EPBYearly return
+46%
Peak return
+116%
Max drawdown
-39%
ADR (20 days)
+6.3%
Base
16 days / -25.0%
Prior run
+49%
Breakout volume
8.2x
Pivot
$35.69
Catalyst Earnings/Guidance2021-07-14The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 RevenuesBenzinga
Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare CLDX with the current market directly.